nodes	percent_of_prediction	percent_of_DWPC	metapath
Captodiame—SIGMAR1—Donepezil—Alzheimer's disease	0.887	1	CbGbCtD
Captodiame—HTR2C—choroid plexus—Alzheimer's disease	0.04	0.414	CbGeAlD
Captodiame—DRD3—telencephalic ventricle—Alzheimer's disease	0.0211	0.218	CbGeAlD
Captodiame—HTR2C—telencephalic ventricle—Alzheimer's disease	0.0117	0.121	CbGeAlD
Captodiame—HTR2C—forebrain—Alzheimer's disease	0.00306	0.0317	CbGeAlD
Captodiame—DRD3—nervous system—Alzheimer's disease	0.00299	0.0309	CbGeAlD
Captodiame—DRD3—central nervous system—Alzheimer's disease	0.00288	0.0298	CbGeAlD
Captodiame—HTR2C—telencephalon—Alzheimer's disease	0.00282	0.0291	CbGeAlD
Captodiame—SIGMAR1—telencephalon—Alzheimer's disease	0.00265	0.0274	CbGeAlD
Captodiame—DRD3—brain—Alzheimer's disease	0.00229	0.0236	CbGeAlD
Captodiame—Dimetacrine—ACHE—Alzheimer's disease	0.00192	0.44	CrCbGaD
Captodiame—HTR2C—nervous system—Alzheimer's disease	0.00166	0.0172	CbGeAlD
Captodiame—HTR2C—central nervous system—Alzheimer's disease	0.0016	0.0165	CbGeAlD
Captodiame—SIGMAR1—cerebellum—Alzheimer's disease	0.00147	0.0152	CbGeAlD
Captodiame—HTR2C—brain—Alzheimer's disease	0.00127	0.0131	CbGeAlD
Captodiame—SIGMAR1—brain—Alzheimer's disease	0.0012	0.0124	CbGeAlD
Captodiame—Tripelennamine—CYP2D6—Alzheimer's disease	0.000487	0.111	CrCbGaD
Captodiame—Chlorphenamine—SLC6A4—Alzheimer's disease	0.000403	0.0921	CrCbGaD
Captodiame—Carbinoxamine—CYP2D6—Alzheimer's disease	0.000333	0.0761	CrCbGaD
Captodiame—Brompheniramine—CYP2D6—Alzheimer's disease	0.000288	0.0659	CrCbGaD
Captodiame—Chlorphenamine—CYP2D6—Alzheimer's disease	0.000283	0.0647	CrCbGaD
Captodiame—Diphenhydramine—PTGS1—Alzheimer's disease	0.000282	0.0645	CrCbGaD
Captodiame—Diphenhydramine—CYP2D6—Alzheimer's disease	0.000192	0.0439	CrCbGaD
Captodiame—Promazine—HTR2A—Alzheimer's disease	0.000181	0.0414	CrCbGaD
Captodiame—DRD3—Circadian rythm related genes—NGFR—Alzheimer's disease	5.54e-05	0.00476	CbGpPWpGaD
Captodiame—HTR2C—G alpha (q) signalling events—PLCB1—Alzheimer's disease	5.45e-05	0.00469	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—HTR6—Alzheimer's disease	5.26e-05	0.00452	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	5.19e-05	0.00446	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	5.17e-05	0.00444	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—GAL—Alzheimer's disease	5.03e-05	0.00433	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	4.96e-05	0.00426	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	4.88e-05	0.00419	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	4.75e-05	0.00408	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	4.53e-05	0.00389	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	4.5e-05	0.00387	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	4.42e-05	0.00379	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—PRKCG—Alzheimer's disease	4.39e-05	0.00377	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—GAL—Alzheimer's disease	4.36e-05	0.00375	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	4.12e-05	0.00354	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—PYY—Alzheimer's disease	4.1e-05	0.00353	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—NPY—Alzheimer's disease	3.95e-05	0.0034	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—IAPP—Alzheimer's disease	3.93e-05	0.00338	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	3.93e-05	0.00338	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	3.83e-05	0.00329	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—CRH—Alzheimer's disease	3.82e-05	0.00328	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—LEP—Alzheimer's disease	3.79e-05	0.00325	CbGpPWpGaD
Captodiame—HTR2C—G alpha (q) signalling events—HTR2A—Alzheimer's disease	3.74e-05	0.00321	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PYY—Alzheimer's disease	3.73e-05	0.0032	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—CCR5—Alzheimer's disease	3.67e-05	0.00316	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—NPS—Alzheimer's disease	3.62e-05	0.00311	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—PYY—Alzheimer's disease	3.56e-05	0.00306	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—NOS2—Alzheimer's disease	3.53e-05	0.00303	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—SST—Alzheimer's disease	3.45e-05	0.00296	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—NPY—Alzheimer's disease	3.43e-05	0.00295	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—HTR6—Alzheimer's disease	3.43e-05	0.00294	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	3.41e-05	0.00293	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—IAPP—Alzheimer's disease	3.41e-05	0.00293	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—APP—Alzheimer's disease	3.36e-05	0.00289	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	3.35e-05	0.00287	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	3.33e-05	0.00287	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—CRH—Alzheimer's disease	3.31e-05	0.00284	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—PPARG—Alzheimer's disease	3.3e-05	0.00283	CbGpPWpGaD
Captodiame—HTR2C—G alpha (q) signalling events—F2—Alzheimer's disease	3.28e-05	0.00282	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—GSK3B—Alzheimer's disease	3.28e-05	0.00282	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—CREB1—Alzheimer's disease	3.25e-05	0.00279	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PYY—Alzheimer's disease	3.23e-05	0.00278	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—CDK5—Alzheimer's disease	3.23e-05	0.00278	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—NPS—Alzheimer's disease	3.14e-05	0.00269	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—HTR6—Alzheimer's disease	3.11e-05	0.00267	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—SST—Alzheimer's disease	2.99e-05	0.00257	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—HTR6—Alzheimer's disease	2.97e-05	0.00255	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	2.95e-05	0.00254	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	2.93e-05	0.00252	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	2.92e-05	0.00251	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—APP—Alzheimer's disease	2.92e-05	0.0025	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	2.89e-05	0.00248	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	2.86e-05	0.00246	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—GAL—Alzheimer's disease	2.84e-05	0.00244	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—CDK5—Alzheimer's disease	2.8e-05	0.00241	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—HTR6—Alzheimer's disease	2.7e-05	0.00232	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	2.67e-05	0.0023	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—GAL—Alzheimer's disease	2.58e-05	0.00222	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	2.53e-05	0.00218	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—TTR—Alzheimer's disease	2.52e-05	0.00216	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	2.51e-05	0.00215	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	2.48e-05	0.00213	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—GAL—Alzheimer's disease	2.47e-05	0.00212	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—GAL—Alzheimer's disease	2.24e-05	0.00192	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—NPY—Alzheimer's disease	2.23e-05	0.00192	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.23e-05	0.00192	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—CCR5—Alzheimer's disease	2.22e-05	0.00191	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—IAPP—Alzheimer's disease	2.22e-05	0.00191	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—MAPK8—Alzheimer's disease	2.21e-05	0.0019	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PYY—Alzheimer's disease	2.2e-05	0.00189	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—TTR—Alzheimer's disease	2.18e-05	0.00188	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—HTR2A—Alzheimer's disease	2.18e-05	0.00187	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	2.17e-05	0.00187	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—CRH—Alzheimer's disease	2.16e-05	0.00185	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—NPS—Alzheimer's disease	2.04e-05	0.00176	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—NPY—Alzheimer's disease	2.03e-05	0.00174	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—IAPP—Alzheimer's disease	2.02e-05	0.00173	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—CRH—Alzheimer's disease	1.96e-05	0.00168	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—GAB2—Alzheimer's disease	1.95e-05	0.00168	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—SST—Alzheimer's disease	1.95e-05	0.00168	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—NPY—Alzheimer's disease	1.94e-05	0.00166	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	1.94e-05	0.00166	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—CCR5—Alzheimer's disease	1.93e-05	0.00166	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—IAPP—Alzheimer's disease	1.93e-05	0.00165	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PYY—Alzheimer's disease	1.91e-05	0.00164	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—CDK5—Alzheimer's disease	1.91e-05	0.00164	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—F2—Alzheimer's disease	1.91e-05	0.00164	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—APP—Alzheimer's disease	1.9e-05	0.00163	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—HTR2A—Alzheimer's disease	1.89e-05	0.00162	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—CRH—Alzheimer's disease	1.87e-05	0.00161	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—NPS—Alzheimer's disease	1.86e-05	0.00159	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.85e-05	0.00159	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—HTR6—Alzheimer's disease	1.84e-05	0.00158	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.79e-05	0.00154	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—NPS—Alzheimer's disease	1.77e-05	0.00152	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—SST—Alzheimer's disease	1.77e-05	0.00152	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—GAB2—Alzheimer's disease	1.77e-05	0.00152	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—NPY—Alzheimer's disease	1.76e-05	0.00151	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—IAPP—Alzheimer's disease	1.75e-05	0.0015	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—APP—Alzheimer's disease	1.73e-05	0.00148	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—CCL2—Alzheimer's disease	1.7e-05	0.00146	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—CRH—Alzheimer's disease	1.7e-05	0.00146	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—GAB2—Alzheimer's disease	1.69e-05	0.00145	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—SST—Alzheimer's disease	1.69e-05	0.00145	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PSENEN—Alzheimer's disease	1.67e-05	0.00143	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—CDK5—Alzheimer's disease	1.66e-05	0.00142	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—F2—Alzheimer's disease	1.65e-05	0.00142	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—APP—Alzheimer's disease	1.65e-05	0.00142	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—APH1A—Alzheimer's disease	1.65e-05	0.00141	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PLCB1—Alzheimer's disease	1.63e-05	0.0014	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—NPS—Alzheimer's disease	1.61e-05	0.00138	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NCSTN—Alzheimer's disease	1.6e-05	0.00138	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.6e-05	0.00138	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—HTR6—Alzheimer's disease	1.59e-05	0.00137	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—LRP1—Alzheimer's disease	1.56e-05	0.00134	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.55e-05	0.00134	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—TP53—Alzheimer's disease	1.54e-05	0.00133	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—SST—Alzheimer's disease	1.54e-05	0.00132	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—GAB2—Alzheimer's disease	1.54e-05	0.00132	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GAL—Alzheimer's disease	1.53e-05	0.00131	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GFAP—Alzheimer's disease	1.53e-05	0.00131	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—APP—Alzheimer's disease	1.5e-05	0.00129	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—CCL2—Alzheimer's disease	1.47e-05	0.00127	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PSENEN—Alzheimer's disease	1.45e-05	0.00124	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—APH1A—Alzheimer's disease	1.43e-05	0.00123	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—IL6—Alzheimer's disease	1.41e-05	0.00121	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PLCB1—Alzheimer's disease	1.41e-05	0.00121	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NCSTN—Alzheimer's disease	1.39e-05	0.00119	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—LRP1—Alzheimer's disease	1.35e-05	0.00116	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—A2M—Alzheimer's disease	1.35e-05	0.00116	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.33e-05	0.00114	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GAL—Alzheimer's disease	1.32e-05	0.00114	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GFAP—Alzheimer's disease	1.32e-05	0.00114	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PSEN2—Alzheimer's disease	1.3e-05	0.00112	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—CCR5—Alzheimer's disease	1.26e-05	0.00108	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.23e-05	0.00106	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PRKCG—Alzheimer's disease	1.2e-05	0.00103	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NPY—Alzheimer's disease	1.2e-05	0.00103	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IAPP—Alzheimer's disease	1.19e-05	0.00102	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—A2M—Alzheimer's disease	1.17e-05	0.001	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.16e-05	0.000998	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—CRH—Alzheimer's disease	1.16e-05	0.000994	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.15e-05	0.000988	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—CCR5—Alzheimer's disease	1.14e-05	0.00098	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PSEN2—Alzheimer's disease	1.13e-05	0.00097	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—HTR2A—Alzheimer's disease	1.12e-05	0.000959	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NPS—Alzheimer's disease	1.1e-05	0.000942	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PPP3CA—Alzheimer's disease	1.09e-05	0.000937	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—CCR5—Alzheimer's disease	1.09e-05	0.000936	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—F2—Alzheimer's disease	1.08e-05	0.000926	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PTK2B—Alzheimer's disease	1.08e-05	0.000924	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.07e-05	0.000916	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GAB2—Alzheimer's disease	1.05e-05	0.000899	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—SST—Alzheimer's disease	1.05e-05	0.000899	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NTRK2—Alzheimer's disease	1.05e-05	0.000899	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PRKCG—Alzheimer's disease	1.04e-05	0.000897	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—CALM1—Alzheimer's disease	1.04e-05	0.000895	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NPY—Alzheimer's disease	1.04e-05	0.000893	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GSK3A—Alzheimer's disease	1.04e-05	0.000891	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IAPP—Alzheimer's disease	1.03e-05	0.000888	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—APP—Alzheimer's disease	1.02e-05	0.000876	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—CRH—Alzheimer's disease	1e-05	0.000862	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—CCR5—Alzheimer's disease	9.89e-06	0.00085	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—F2—Alzheimer's disease	9.79e-06	0.000841	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—HTR2A—Alzheimer's disease	9.68e-06	0.000832	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PLCB1—Alzheimer's disease	9.62e-06	0.000826	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NPS—Alzheimer's disease	9.51e-06	0.000817	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PPP3CA—Alzheimer's disease	9.46e-06	0.000813	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—F2—Alzheimer's disease	9.35e-06	0.000803	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PTK2B—Alzheimer's disease	9.32e-06	0.000801	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—SST—Alzheimer's disease	9.07e-06	0.000779	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NTRK2—Alzheimer's disease	9.07e-06	0.000779	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GAB2—Alzheimer's disease	9.07e-06	0.000779	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—CALM1—Alzheimer's disease	9.03e-06	0.000776	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GSK3A—Alzheimer's disease	8.99e-06	0.000772	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NGFR—Alzheimer's disease	8.97e-06	0.000771	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—CREB1—Alzheimer's disease	8.92e-06	0.000766	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—APP—Alzheimer's disease	8.84e-06	0.000759	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ADAM10—Alzheimer's disease	8.77e-06	0.000753	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—CCL2—Alzheimer's disease	8.73e-06	0.00075	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—F2—Alzheimer's disease	8.49e-06	0.000729	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PLCB1—Alzheimer's disease	8.34e-06	0.000717	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—S100B—Alzheimer's disease	8.29e-06	0.000712	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IGF2—Alzheimer's disease	7.89e-06	0.000678	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NGFR—Alzheimer's disease	7.78e-06	0.000669	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—CREB1—Alzheimer's disease	7.73e-06	0.000664	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IGF1R—Alzheimer's disease	7.63e-06	0.000656	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ADAM10—Alzheimer's disease	7.6e-06	0.000653	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—CCL2—Alzheimer's disease	7.57e-06	0.00065	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—LPL—Alzheimer's disease	7.32e-06	0.000629	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—MEF2C—Alzheimer's disease	7.25e-06	0.000623	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—S100B—Alzheimer's disease	7.19e-06	0.000618	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PRKCG—Alzheimer's disease	7.11e-06	0.000611	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NGF—Alzheimer's disease	6.93e-06	0.000595	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IGF2—Alzheimer's disease	6.84e-06	0.000588	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—CCR5—Alzheimer's disease	6.74e-06	0.000579	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IGF1R—Alzheimer's disease	6.62e-06	0.000568	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—HTR2A—Alzheimer's disease	6.6e-06	0.000567	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—LPL—Alzheimer's disease	6.34e-06	0.000545	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—MEF2C—Alzheimer's disease	6.29e-06	0.00054	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PRKCG—Alzheimer's disease	6.17e-06	0.00053	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—CALM1—Alzheimer's disease	6.15e-06	0.000529	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—APOE—Alzheimer's disease	6.13e-06	0.000527	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—LEP—Alzheimer's disease	6.13e-06	0.000527	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—CAV1—Alzheimer's disease	6.08e-06	0.000522	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NGF—Alzheimer's disease	6.01e-06	0.000516	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ESR1—Alzheimer's disease	5.85e-06	0.000503	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—CCR5—Alzheimer's disease	5.84e-06	0.000502	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—F2—Alzheimer's disease	5.78e-06	0.000497	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—HTR2A—Alzheimer's disease	5.72e-06	0.000491	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NOTCH1—Alzheimer's disease	5.66e-06	0.000486	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	5.34e-06	0.000458	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	5.32e-06	0.000457	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	5.32e-06	0.000457	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GSK3B—Alzheimer's disease	5.31e-06	0.000456	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	5.27e-06	0.000453	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—CREB1—Alzheimer's disease	5.27e-06	0.000453	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—INS—Alzheimer's disease	5.24e-06	0.00045	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—CCL2—Alzheimer's disease	5.15e-06	0.000443	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	5.08e-06	0.000436	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IGF1—Alzheimer's disease	5.07e-06	0.000435	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—F2—Alzheimer's disease	5.01e-06	0.000431	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	4.91e-06	0.000422	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	4.6e-06	0.000396	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NOS3—Alzheimer's disease	4.59e-06	0.000395	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	4.57e-06	0.000392	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—INS—Alzheimer's disease	4.54e-06	0.00039	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	4.47e-06	0.000384	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	4.39e-06	0.000377	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	3.98e-06	0.000342	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	3.94e-06	0.000338	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	3.9e-06	0.000335	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	3.88e-06	0.000333	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	3.58e-06	0.000308	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	3.57e-06	0.000307	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.41e-06	0.000293	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	3.38e-06	0.000291	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	3.36e-06	0.000289	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	3.31e-06	0.000284	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	3.11e-06	0.000267	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	3.1e-06	0.000266	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	3.04e-06	0.000261	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.87e-06	0.000247	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.63e-06	0.000226	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—TP53—Alzheimer's disease	2.5e-06	0.000215	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IL6—Alzheimer's disease	2.29e-06	0.000197	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	2.17e-06	0.000186	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	2.11e-06	0.000181	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.98e-06	0.000171	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.83e-06	0.000157	CbGpPWpGaD
